197 related articles for article (PubMed ID: 32107559)
1. Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Ronner L; Podoltsev N; Gotlib J; Heaney ML; Kuykendall AT; O'Connell C; Shammo J; Fleischman AG; Scherber RM; Mesa R; Yacoub A; Perkins C; Meckstroth S; Behlman L; Chiaramonte M; Salehi M; Ziadkhanpour K; Nguyen H; Siwoski O; Hung AK; Janania Martinez M; Nguyen J; Patel S; Kollipara R; Dave A; Randall M; Grant M; Harrison M; Fernandez Soto P; Tremblay D; Hoffman R; Moshier E; Mascarenhas J
Blood; 2020 May; 135(19):1696-1703. PubMed ID: 32107559
[TBL] [Abstract][Full Text] [Related]
2. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis.
Passamonti F; Rumi E; Caramella M; Elena C; Arcaini L; Boveri E; Del Curto C; Pietra D; Vanelli L; Bernasconi P; Pascutto C; Cazzola M; Morra E; Lazzarino M
Blood; 2008 Apr; 111(7):3383-7. PubMed ID: 18187660
[TBL] [Abstract][Full Text] [Related]
3. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
4. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
5. Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications.
Boiocchi L; Gianelli U; Iurlo A; Fend F; Bonzheim I; Cattaneo D; Knowles DM; Orazi A
Mod Pathol; 2015 Nov; 28(11):1448-57. PubMed ID: 26336886
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.
Bai J; Xue Y; Ye L; Yao J; Zhou C; Shao Z; Qian L; Yang R; Li H; Zhang H; Zheng Y
Int J Hematol; 2008 Dec; 88(5):530-535. PubMed ID: 19002391
[TBL] [Abstract][Full Text] [Related]
7. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract][Full Text] [Related]
8. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
[TBL] [Abstract][Full Text] [Related]
9. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
[TBL] [Abstract][Full Text] [Related]
10. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
Landolfi R; Di Gennaro L; Barbui T; De Stefano V; Finazzi G; Marfisi R; Tognoni G; Marchioli R;
Blood; 2007 Mar; 109(6):2446-52. PubMed ID: 17105814
[TBL] [Abstract][Full Text] [Related]
11. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M
Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Passamonti F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
Passamonti F; Rumi E; Pietra D; Elena C; Boveri E; Arcaini L; Roncoroni E; Astori C; Merli M; Boggi S; Pascutto C; Lazzarino M; Cazzola M
Leukemia; 2010 Sep; 24(9):1574-9. PubMed ID: 20631743
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs.
Crisà E; Venturino E; Passera R; Prina M; Schinco P; Borchiellini A; Giai V; Ciocca Vasino MA; Bazzan M; Vaccarino A; Boccadoro M; Ferrero D
Ann Hematol; 2010 Jul; 89(7):691-9. PubMed ID: 20146064
[TBL] [Abstract][Full Text] [Related]
15. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
[TBL] [Abstract][Full Text] [Related]
16. The haematocrit and platelet target in polycythemia vera.
Di Nisio M; Barbui T; Di Gennaro L; Borrelli G; Finazzi G; Landolfi R; Leone G; Marfisi R; Porreca E; Ruggeri M; Rutjes AW; Tognoni G; Vannucchi AM; Marchioli R;
Br J Haematol; 2007 Jan; 136(2):249-59. PubMed ID: 17156406
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
Barbui T; Carobbio A; Rambaldi A; Finazzi G
Blood; 2009 Jul; 114(4):759-63. PubMed ID: 19372254
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic myeloid metaplasia. Its evolution into acute leukemia.
Silverstein MN; Brown AL; Linman JW
Arch Intern Med; 1973 Nov; 132(5):709-12. PubMed ID: 4518465
[No Abstract] [Full Text] [Related]
19. Thrombotic complications of polycythemia vera.
Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group.
Dan K; Yamada T; Kimura Y; Usui N; Okamoto S; Sugihara T; Takai K; Masuda M; Mori M;
Int J Hematol; 2006 Jun; 83(5):443-9. PubMed ID: 16787877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
